<DOC>
	<DOCNO>NCT02080000</DOCNO>
	<brief_summary>The aim study investigate whether use simple feature 12 lead electrocardiogram ( ECG ) optimise pacemaker device program clinically relevant benefit patient management . More specifically investigate whether use R-wave V1 surface ECG guide timing leave ( LV ) right ventricular ( RV ) pace improves response Cardiac Resynchronisation Therapy .</brief_summary>
	<brief_title>R-wave Optimisation Cardiac Resynchronisation Therapy Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>Inclusion Criteria The patient must biventricular pacemaker situ , implant NYHA Class III / IV heart failure syndrome impair systolic function . Implantation indication must include leave ventricular ejection fraction measure transthoracic echo &lt; 35 % either QRS duration &gt; 150ms QRS duration 120 149ms evidence dyssynchrony confirm echocardiography . Participants must &gt; 95 % true biventricular pace 1 month enrolment throughout observation period . The biventricular pace QRS complex morphology lead V1 subject 's standard 12 lead surface ECG must show R wave height &lt; 1mm &lt; 20 % total QRS deflection standard LV offset setting apply . The subject 's standard 12 lead surface ECG must show right bundle branch block pattern lead V1 LV pacing . The participant must willing comply protocol requirement include travel Royal Bournemouth Hospital attendance require study intend long term device follow Royal Bournemouth Hospital time enrolment . Provision inform consent Exclusion criterion Hypertrophic restrictive cardiomyopathy Suspected acute myocarditis Correctable Valvulopathy An Acute Coronary Syndrome within last 3 month Recent ( within last 3 month ) schedule coronary revascularisation Treatment resistant hypertension Severe obstructive lung disease Pregnancy time enrolment desire become pregnant study period An inability walk Reduced life expectancy associate cardiovascular disease ( less 1 year ) Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronisation Therapy</keyword>
	<keyword>Biventricular Pacemaker</keyword>
	<keyword>Optimisation</keyword>
</DOC>